Pharming Group (OTCMKTS:PHGUF – Get Free Report)’s stock price hit a new 52-week low on Tuesday . The stock traded as low as $1.07 and last traded at $1.07, with a volume of 0 shares changing hands. The stock had previously closed at $1.07.
Pharming Group Stock Performance
The firm has a 50 day moving average of $1.18 and a two-hundred day moving average of $1.17. The stock has a market cap of $694.82 million, a P/E ratio of -106.50 and a beta of 1.07. The company has a debt-to-equity ratio of 0.76, a quick ratio of 3.33 and a current ratio of 4.06.
Pharming Group Company Profile
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks.
See Also
- Five stocks we like better than Pharming Group
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Silicon Motion Proves That AI in Motion Stays in Motion
- Stock Market Upgrades: What Are They?
- Undervalued UnitedHealth Group Won’t Be For Long
- Stock Sentiment Analysis: How it Works
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
